Compare AbCellera Biologics Inc (ABCL) vs Campbell Soup Co. (CPB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Campbell Soup Co. — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Campbell Soup Co. trades at $22.71 (market cap $6.78B). The key difference: Campbell Soup Co. is far larger — about 2.3× AbCellera Biologics Inc's market cap, and Campbell Soup Co. pays a 6.87% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CPB | |
|---|---|---|
Market Cap | $2.99B | $6.78B |
Sector | Health | Consumer Staples |
52-Week High | $9.76 | $34.03 |
52-Week Low | $2.78 | $20.00 |
Enterprise Value | $2.58B | $13.38B |
Dividend Yield | — | 6.87% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Campbell Soup Co.
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →
